Cadence Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,949
Closed -$4.61M 199
2021
Q4
$4.61M Buy
9,949
+128
+1% +$53.9K 0.58% 49
2021
Q3
$3.66M Buy
9,821
+189
+2% +$71.8K 0.51% 52
2021
Q2
$3.68M Buy
9,632
+92
+1% +$35.2K 0.53% 48
2021
Q1
$3.42M Buy
9,540
+562
+6% +$181K 0.52% 50
2020
Q4
$2.88M Buy
8,978
+396
+5% +$122K 0.45% 58
2020
Q3
$2.31M Buy
8,582
+23
+0.3% +$6.19K 0.45% 53
2020
Q2
$2.25M Buy
+8,559
New +$2.28M 0.46% 55

Other funds holding ELV

Cadence Bank's ELV Position: Q1 2022 in Review

Cadence Bank sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 9,949 shares — an estimated $4.61M sold.

Cadence Bank first reported a position in ELV in Q2 2020 and held it in 7 quarters. The position peaked at $4.61M in Q4 2021. 1,419 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

  • Cadence Bank reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
  • Cadence Bank sold 9,949 Elevance Health shares in Q1 2022, an estimated $4.61M.
  • Cadence Bank first reported a position in Elevance Health in Q2 2020 and held it in 7 quarters.
  • Cadence Bank's Elevance Health position peaked at $4.61M in Q4 2021.
  • 1,419 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Cadence Bank's 13F filing for Q1 2022, filed 13 May 2022.